FDA Advisory Panel Votes Not to Recommend Covid Booster for People 16 and Older
Initial Vote By FDA Advisory Panel Fails to Recommend Covid-19 Booster Doses for People 16 Years and Older
Related Articles
Drugs Like Ozempic Created a Gold Rush. These Drugmakers Want In.
Companies developing weight-loss drugs have raised or made deals valued at more than $1.4 billion since about a year ago.
Lots of Tap Water Contains ‘Forever Chemicals.’ Take These Steps to Reduce Your Risk.
You can’t avoid toxic PFAS chemicals completely but can you can lessen your exposure at home.
Essay | Do Younger or Older Doctors Get Better Results?
A physician’s effectiveness has less to do with age than with how many patients they see and how well they keep up to date on…
Bosses Are Catching Job Applicants Using ChatGPT for a Boost
As AI reaches the masses, workers are using it to dress up job applications and résumés.
To Treat Extreme Heat, Ice-Packed Body Bags and Wet Gowns
Ice, water and fans are among the remedies for nausea, muscle cramps and comas caused by high body temperatures.
Europeans Are Becoming Poorer. ‘Yes, We’re All Worse Off.’
An aging population that values its free time set the stage for economic stagnation. Then came Covid-19 and Russia’s war in Ukraine.
Essay | What if We Could Get Rid of Menopause?
New efforts to boost women’s health and extend fertility depend on developing tools to slow the aging of ovaries.
‘Credible’ Review: Talent at the Top
Should a doctor run a hospital? An engineer a tech company? Workers seem to value a boss with skill and knowledge in the core business.
Europeans Are Becoming Poorer. ‘Yes, We’re All Worse Off.’
An aging population that values its free time set the stage for economic stagnation. Then came Covid-19 and Russia’s war in Ukraine.
